Genomic Health (GHDX) Tops Q3 EPS by 7c

November 4, 2009 4:41 PM EST

Genomic Health, Inc. (NASDAQ: GHDX) reports Q3 loss of $0.02, 7 cents better than the analyst estimate of ($0.09). Revenue for the quarter was $39.5 million, which compares to the estimate of $39.11 million.


Related Categories

Earnings

Stocks Mentioned

GHDX 19.29

+0.25 +1.31%
Volume: 57,344
Track GHDX


Add Your Comment